About Us
EN
ENCN
Annals of Biomedical EngineeringJournal Home
Annals of Biomedical Engineering is an interdisciplinary, international journal which presents original and review articles in the major fields of bioengineering and biomedical engineering. A major aim of bioengineering is to provide integrated approaches to the solutions of biological and biomedical problems. The philosophy is to provide engineering approaches to enhance the power of the scientific method, and to maintain a balance between experimental observation and quantitative analyses. While the development of theory and of mathematical models is strongly endorsed, these should be evaluated wherever possible using biological data from experiments that test specific hypotheses. This is the official journal of the Biomedical Engineering Society. The average time from submission to first decision is three weeks. After acceptance, articles are published online in about two weeks. General Details on the Submission and Publication Procedures: - No Page Charges - No Fees for Online and Print Color Images Why publish with us As an official journal of the Biomedical Engineering Society, we welcome research in the fields of bioengineering and biomedical engineering. Founded in 1968, the Society now boasts over 7,500 members worldwide and is growing rapidly. We ensure that your article can be easily discovered, accessed, understood, used and shared - and act as a springboard for further discovery Through Springer Compact agreements, authors from participating institutions can publish Open Choice at no cost to the authors.
Publishing Model：
ISSN：0090-6964
|EISSN：1573-9686
|Publication Frequency：12 times a year
|Last updated on 01 Mar 2026 / Current volume： 逦鋺 / Current issue： 杚
More Details
Biomedical Engineering
Impact Factor
Journal Impact Factor(JIF) 2024
逦.鋺
Journal Citation Indicator(JCI) 2024
蔡.炆躭
Web of Science Rank 2024:
乊沟佥喊沟乊乊葤喊沟佥, 愨喊鵣胦乊枀喊。嵻欄
# 缗炆/声缗鋺
79.44%
Q1
CiteScore Metrics
CiteScore 2024
炆.杚
=
逦杚鋺䟕 Citation （2022-2024）
躭鋺炆 Article （2022-2024）
CiteScore Rank 2024
愨嚷肃陱蠹罒嚷桧囹⻊ 乊鵃茡嚷鵃蠹蠹㥌嚷鵃茡
# 声声声/杚缗杚
65.63%
Q2
